BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 17304103)

  • 1. The tumor necrosis factor alpha -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia.
    Kovar FM; Marsik C; Cvitko T; Wagner OF; Jilma B; Endler G
    Shock; 2007 Mar; 27(3):238-41. PubMed ID: 17304103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo.
    Kovar FM; Marsik C; Jilma B; Mannhalter C; Quehenberger P; Handler S; Wagner OF; Endler G
    Thromb Res; 2007; 120(5):727-31. PubMed ID: 17303222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
    Schippers EF; van 't Veer C; van Voorden S; Martina CA; Huizinga TW; le Cessie S; van Dissel JT
    Cytokine; 2005 Mar; 29(5):215-28. PubMed ID: 15760678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-alpha promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
    Schippers EF; van 't Veer C; van Voorden S; Martina CA; le Cessie S; van Dissel JT
    Cytokine; 2004 Apr; 26(1):16-24. PubMed ID: 15016407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis].
    Zhang D; Li J; Jiang Z; Yu B; Tang X
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1529-31. PubMed ID: 12609060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Plasma C-reactive protein in chronically distressed subjects who carry the A allele of the TNF-alpha -308 G/A polymorphism.
    Jeanmonod P; von Känel R; Maly FE; Fischer JE
    Psychosom Med; 2004; 66(4):501-6. PubMed ID: 15272094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
    Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
    Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases.
    Cipriano C; Caruso C; Lio D; Giacconi R; Malavolta M; Muti E; Gasparini N; Franceschi C; Mocchegiani E
    Int J Immunogenet; 2005 Feb; 32(1):13-8. PubMed ID: 15686588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression.
    Jeong P; Kim EJ; Kim EG; Byun SS; Kim CS; Kim WJ
    Urology; 2004 Nov; 64(5):1052-6. PubMed ID: 15533517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTM1 and TNF-alpha gene polymorphisms and relations between blood lead and inflammatory markers in a non-occupational population.
    Kim JH; Lee KH; Yoo DH; Kang D; Cho SH; Hong YC
    Mutat Res; 2007 Apr; 629(1):32-9. PubMed ID: 17298885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of G308A polymorphism of tumor necrosis factor-alpha gene on inflammatory markers in postsurgical head and neck cancer patients with early enteral nutrition.
    de Luis DA; Sagrado MG; Vallejo LA; Carcedo LM; Izaola O; Cuellar L; Terroba MC; Aller R
    Nutrition; 2007; 23(7-8):529-32. PubMed ID: 17560079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia.
    Marsik C; Sunder-Plassmann R; Jilma B; Kovar FM; Mannhalter C; Wagner O; Rumpold H; Endler G
    Clin Chem; 2006 Oct; 52(10):1952-7. PubMed ID: 16916988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD14-260 C --> T promoter polymorphism co-segregates with the tumor necrosis factor-alpha (TNF-alpha)-308 G --> A polymorphism and is associated with the interleukin-1 beta (IL-1 beta) synthesis capacity of human leukocytes.
    Heesen M; Bloemeke B; Bachmann-Mennenga B; Kunz D
    Eur Cytokine Netw; 2002; 13(2):230-3. PubMed ID: 12101079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha gene promoter polymorphism at nucleotide -308 and the inflammatory response and oxidative stress induced by cardiac surgery: role of heart failure and medical treatment.
    Galiñanes M; James M; Codd V; Baxi A; Hadjinikolaou L
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):332-7. PubMed ID: 18450464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha -308G>A polymorphism modulates cytokine serum concentrations and macrovascular complications in diabetic patients on aspirin.
    Krayenbuehl PA; Wiesli P; Schmid M; Schmid C; Ehses JA; Hersberger M; Vetter W; Schulthess G
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):322-6. PubMed ID: 17516296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the G-308A polymorphism of the tumor necrosis factor (TNF)-alpha gene promoter site on plasma levels of TNF-alpha and C-reactive protein in smokers: a cross-sectional study.
    Gander ML; Fischer JE; Maly FE; von Känel R
    BMC Cardiovasc Disord; 2004 Oct; 4():17. PubMed ID: 15485576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease.
    Schäfer C; Schips I; Landig J; Bode JC; Bode C
    Z Gastroenterol; 1995 Sep; 33(9):503-8. PubMed ID: 8525652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
    Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
    Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells.
    Ostrowski SR; Plomgaard P; Fischer CP; Steensberg AS; Møller K; Høyer-Hansen G; Pedersen BK; Ullum H
    Scand J Immunol; 2005 Feb; 61(2):197-206. PubMed ID: 15683457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.